| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Division of Endocrinology, Diabetes, and Hypertension (J.C.G., E.J., U.B.K.), Brigham and Womens Hospital, Harvard Medical School, Boston, Massachusetts 02115; Department of Biomedical Sciences (B.W., S.T.), Colorado State University, Fort Collins, Colorado 80523; Departments of Medicine and Cell Biology (P.C., S.M.M.), University of Virginia, Charlottesville, Virginia 22908; Department of Molecular and Human Genetics (W.P., A.R., S.M.), Baylor College of Medicine, Houston, Texas 77030; and Department of Cell Biology (G.A.S.), University of Massachusetts Medical School, Waltham, Massachusetts 01655
Address all correspondence and requests for reprints to: Ursula B. Kaiser, 221 Longwood Avenue, Division of Endocrinology, Diabetes and Hypertension, Brigham and Womens Hospital, Boston, Massachusetts 02115. E-mail: ukaiser{at}partners.org.
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
and fibroblast growth factors) (4, 5) that first locally affect fate specification of GnRH neurons, and then on combinations of factors [e.g. nasal embryonic LHRH factor (NELF),
-amino butyric acid (GABA), netrins] that directly affect GnRH neuron migration and axon targeting of the ME (6, 7, 8, 9). A potential autocrine role of GnRH itself in the development and function of GnRH neurons has been proposed from studies of the GnRH-deficient hypogonadal (hpg) mouse (10). A deletion of the Gnrh1 gene results in hpg mice that do not synthesize GnRH decapeptide (10). Previous examination of the distribution of GnRH neurons in the GnRH-deficient hpg mouse model was dependent upon detection of a short 5' segment of GnRH mRNA because the deletion prevented transcription of the complete coding sequence and the production of detectable levels of peptide (10, 11). GnRH mRNA levels as measured by in situ hybridization in adult hpg mouse brains were greatly reduced, detecting only 16–20% of the normal GnRH neuronal population size (10, 11). The reduction in GnRH neuron number in hpg mice was attributed to either of two explanations. One hypothesis was that the truncated GnRH mRNA produced in the presence of the gene deletion was rendered unstable, resulting in accelerated degradation of the transcript with reduced cellular levels such that 80% of hpg GnRH neurons escaped detection by in situ hybridization (10, 11). An alternative possibility was that a GnRH peptide is necessary during development for GnRH neuron proliferation, migration, or survival, resulting in the loss of 80% of the population in the absence of GnRH. This potential reduction of GnRH neurons may explain the results of our recent study using targeted viral vectors that identified only a small number of hpg GnRH neurons (12). The embryonic expression of the ligand and GnRH receptor (GnRHR) is consistent with a developmental role for GnRH (1, 2, 13); however, the role of GnRH as a candidate trophic factor on GnRH neurons in vivo remains unproven.
GnRH stimulation of pituitary gonadotropes activates the GnRHR, a G protein-coupled receptor, to release LH and FSH in large part through Gq
and G11
activation, effecting calcium mobilization to induce gonadotropin secretion (14, 15, 16). GnRHR activation of alternative signaling pathways in other nonpituitary tissues has been described, thus broadening the potential physiological roles of GnRH. These include evidence of a neuromodulatory role in amphibians to increase arterial blood pressure via catecholamine release (17), in sensory transmission in the visual system (18), and in chemosensory reception in both the vomeronasal and the olfactory systems (19, 20), implicating the ability of GnRH to directly regulate other neurons. Autocrine roles of GnRH in the ovary, a tissue that expresses both GnRH and GnRHR, have been demonstrated because GnRH has antiproliferative and apoptosis-inducing effects in human ovarian surface epithelium and ovarian cancer, as well as in gynecological cancers (21, 22, 23, 24). Recently, GnRH stimulation of slice cultures of pituitary tissue has demonstrated the ability to induce mobilization and reorganization of the gonadotrope cell cytoarchitecture (25). These broad examples suggest that GnRH can have potent and variable effects on development in addition its role in regulating pituitary gonadotropin secretion.
In mice, the earliest developmental expression of GnRH begins at embryonic d 10.5 in the nasal placode (26). The transcriptional activity of the Gnrh1 gene has been used to define the GnRH neuron because no other specific and unique marker to identify these cells has been demonstrated. The migration phase of development coincides with GnRHR expression on GnRH neurons (27), suggesting that GnRH may act as a regulatory factor during this period. Activation of the GnRHR in GnRH neuronal cell lines, primary GnRH neurons, and adult GnRH neurons in hypothalamic slice preparations has been shown to stimulate physiological responses, although trophic actions mediated by GnRHR have yet to be demonstrated in GnRH neurons in vivo (27, 28).
To determine whether GnRH indeed plays a critical role in the establishment or the maintenance of GnRH neurons in vivo, GnRH neurons were studied in different hypogonadal mouse models: GnRH-deficient hpg mice (10) and GnRHR-mutant mice (Gnrhrmut/mut) (29). These GnRH signaling-deficient models were examined for GnRH neuron numbers, distribution, and electrophysiological firing activity. Because detection of GnRH cannot be used to identify GnRH neurons in hpg mice, mice heterozygous for the hpg mutation were crossed with transgenic mice with targeted green fluorescent protein (GFP) expression in GnRH neurons (30). Mice resulting from this cross allowed the visualization of hypothalamic GnRH neurons with GnRH-GFP expression and activity, thus facilitating analysis of the mutant GnRH neuronal population and distribution even in the absence of GnRH.
| Materials and Methods |
|---|
|
|
|---|
GnRH-deficient hpg mice
Mice heterozygous for the Gnrh1 gene deletion (Gnrh1+/ –; HET) in the C3H/HeHx101/H background strain were obtained from The Jackson Laboratory (Bar Harbor, ME). HET mice are fertile and generated wild-type (Gnrh1+/+; WT), HET, and homozygous (Gnrh1–/–; hpg) mice in Mendelian ratios. Genotypes of offspring were determined by PCR of genomic tail DNA with three primers: primer 1: 5'-TATGGCTTACAGTTCCAGCG (sense, intron two, upstream of the deletion); primer 2: 5'-AGGCTTGGAGAGCTGTAAGG (antisense, intron two, within the deleted region); primer 3: 5'-GTTTCAGTGCATCCTCTCAGG (antisense, downstream of the deleted region). Primers 1 and 2 are expected to generate a PCR product of 613 bp in size from the WT allele, and primers 1 and 3 are expected to generate a 536-bp product from the mutant allele.
GnRH-deficient GnRH-GFP mice
To facilitate the visualization of GnRH neurons in the brains of hpg mice devoid of immunoreactive GnRH, HET mice were crossed with transgenic mice engineered to specifically express enhanced GFP as a targeted reporter in GnRH neurons (30). A breeding pair [heterozygous for the Gnrh1 mutation and positive for the GnRH-GFP transgene; (HET/GFP)] was generated and used as founders to generate all subsequent GnRH-GFP reporter mice used for this study. PCR genotyping of genomic tail DNA was performed for the Gnrh1 gene as described above. The presence of the GnRH-GFP transgene was confirmed by PCR with GFP primers (forward, 5'-GACGTAAACGGCCAAAGTT; reverse, 5'-AAGTCGTGCTGCTTCATGTG).
Gnrhr mutant mice
Homozygous Gnrhrmut/mut mice and their WT littermates were generated by crossing heterozygotes in a breeding colony maintained at Baylor College of Medicine. Genotypes were determined as previously reported (29) using PCR and primers in the flanking genomic sequence (forward, 5'-CTCCACTCTTGAAGCCTGTCC; reverse, 5'-TCACCATGTTCACACAAATTC) followed by DdeI digestion of the amplified products. The mice were maintained in a 129S6/SvEv background strain.
Immunocytochemistry and analysis of GnRH and GnRH-GFP neurons
Adult male mice (8 wk old) were anesthetized, transcardially perfused with 10–20 ml saline followed by 10–20 ml of 4% paraformaldehyde in 0.1 M PBS (PBS; pH 7.4) using a 26-gauge needle and hand-held syringe. Testes were removed and imaged. Brains were dissected, post-fixed in 4% paraformaldehyde, cryoprotected in 20% sucrose solution, 0.01% sodium azide, and cryosectioned (Microm International GmbH, Walldorf, Germany) in the coronal plane from the accessory olfactory bulbs to the ME. For quantitative bright-field microscopy, 40-µm floating sections, or 20-µm thaw-mounted sections, were pretreated with 1% hydrogen peroxide in PBS containing 0.4% Triton X-100 (PBST) for 10 min to remove endogenous peroxidase activity, then incubated with either polyclonal rabbit anti-GnRH antibody (ImmunoStar, Hudson, WI; 1:32,000 dilution) or rabbit anti-GFP (Invitrogen, Carlsbad, CA; 1:10,000) in 10% normal horse serum, 4% normal donkey serum in PBST for three nights at 4 C. Sections were then incubated with a donkey antirabbit IgG biotinylated secondary antibody (Jackson ImmunoResearch, West Grove, PA) at 1:500 dilution using Vectastain Elite ABC Kit (Vector Laboratories, Burlingame, CA), and visualized with 3,3'-diaminobenzidine tetrahydrochloride (DAB; Pierce, Rockford, IL). Floating brain sections were serially aligned and mounted on glass microscope slides in a rostral to caudal order. After dehydration of sections, the slides were cleared, sealed, and coverslipped with Permount (Fisher Scientific, Pittsburgh, PA).
For immunofluorescence microscopy, 18-µm coronal brain sections were thaw-mounted onto poly-L-lysine coated slides. Slides were incubated in polyclonal goat anti-GFP (Genetex, Inc., San Antonio, TX; 1:5000). The subsequent secondary antibody, donkey antigoat was directly conjugated to Alexa-488 (Molecular Probes, Inc., Eugene, OR; 1:1000) to visualize GFP (green). The slides were mounted, cleared and coverslipped with Vectashield (Vector Laboratories).
Before bright-field and epifluorescence analysis of the numbers and distribution of GnRH and GnRH-GFP neurons, slides were coded to obscure sample identification. GnRH or GnRH-GFP neurons were counted in each section, and imaged at the organum vasculosum of the lamina terminalis (OVLT) and ME. Data for total neuron numbers and neurons counted in the rostral to caudal serial sections aligned at the OVLT as a common anatomical landmark between samples were graphed using Prism statistics software (GraphPad Software, Inc., San Diego, CA).
Immunocytochemistry of Gnrhr mutant mice
Eight-week-old male and female Gnrhrmut/mut mice, previously generated by N-ethyl-N-nitrosourea (ENU)-mutagenesis bear a T to C transition resulting in the missense L117P mutation (29), were transcardially perfused as above but without post-processing brain tissue in sucrose. Brains from Gnrhrmut/mut and WT animals were embedded in 5% agarose and cut coronally at 50 µm using a vibrating microtome (Leica VT1000S, Wetzlar, Germany). Sections were placed free-floating in containers with Nitex (Wildlife Supply Co., Buffalo, NY) mesh bottoms in 0.05 M PBS, pH 7.4. Each brain was cut into three sequential containers so that each antiserum/container used provided a full representation of sections from one third of the adult brain. Sections were pretreated at 4 C as follows: 0.1 M glycine in PBS for 30 min, 0.5% sodium borohydride in PBS for 15 min, and 5% normal goat serum (NGS) with 0.5% Triton X-100 and 1% hydrogen peroxide in PBS for 30 min. Adjacent sections were then incubated in different antisera directed toward GnRH, either LR-1 rabbit antiserum (1:40,000; a generous gift from Dr. Robert Benoit), or a commercial GnRH rabbit antiserum (1:1,000; PA121 obtained from Affinity Bioreagents, Golden, CO) in 1% BSA with 0.5% Tx for 3 nights at 4 C. After primary incubation, sections were washed at room temperature four times for 15 min each in 1% NGS with 0.02% Tx and then incubated with donkey antirabbit IgG biotinylated secondary antibody (Jackson ImmunoResearch) at 1:500 dilution in 1% NGS with 0.32% Tx for 2 h at room temperature. Sections were subsequently rinsed four times in 0.02% Tx-PBS followed by incubation in peroxidase-conjugated streptavidin (Jackson ImmunoResearch; diluted 1:2,500) for 1 h, washed for 1 h in Tris-buffered saline (TBS), and developed with 0.025% 3,3'-diaminobenzidine in TBS with 0.2% nickel ammonium and 0.02% hydrogen peroxide for 5 min. After immunocytochemistry, sections were washed in TBS, mounted on gelatin-subbed slides, dehydrated, and coverslipped with Permount (Fisher Scientific). GnRH-immunoreactive neurons were counted from two containers from each brain immunoreacted for one of two GnRH antisera giving a spread of 150 µm between each analyzed section within either antiserum. GnRH neurons were counted on a BH-2 photomicroscope (Olympus America, Inc., Center Valley, PA) and analyzed as a function of their rostral to caudal distribution centered and aligned at the OVLT.
Electrophysiological recordings of hpg/GFP neurons
To eliminate the effect of steroid milieu on GnRH neurons during electrophysiological recordings, adult (>2 months) female hpg/GFP mice were ovariectomized under isoflurane (Burns Veterinary Supply, Westbury, NY) anesthesia. Postoperative analgesia was provided by a long-acting local anesthetic (bupivacaine, 0.25%, 7.5 µl per site; Abbott Laboratories, North Chicago, IL). Recordings were performed 5–9 d after surgery. Brain slices from WT/GFP, n = 4) and hpg/GFP, n = 7) mice were prepared as previously described (31). Briefly, all solutions were bubbled with a 95% O2/5% CO2 mixture throughout the experiments and for at least 15 min before exposure to the tissue. Mice were decapitated, and the brain was rapidly removed and placed in ice-cold, high-sucrose saline solution containing (in mM) 250 sucrose, 3.5 KCl, 26 NaHCO3, 10 glucose, 1.25 Na2HPO4, 1.2 MgSO4, and 2.5 MgCl2. Coronal 300-µm brain slices were cut with a Vibratome 3000 (Technical Products, International, Inc., St. Louis, MO). Slices were incubated for 30 min at 30–32 C in a solution of 50% high-sucrose saline and 50% normal saline (NS) containing (in mM) 135 NaCl, 3.5 KCl, 10 glucose, 1.3 Na2HPO4, 1.2 MgSO4, and 2.5 CaCl2 and then were transferred to a solution of 100% NS at room temperature and kept at least 60 min and no more than 8 h before recording.
Targeted extracellular recordings were used for this study (32). Brain slices are placed in a recording chamber continuously superfused with oxygenated NS solution and kept at 30–32 C and mounted on an Olympus BX51WI upright fluorescent microscope with infrared differential interference contrast optics (Opelco, Dulles, VA). Recording pipettes (2–3 M
) were filled with normal HEPES-buffered solution containing (in mM) 150 NaCl, 10 HEPES, 10 glucose, 2.5 CaCl2, 1.3 MgCl2, and 3.5 KCl. Pipettes were placed in contact with the GnRH neurons using an MP-225 micromanipulator (Sutter Instruments, Novato, CA). No tight seal is formed (seals <50 M
); low resistance seals minimize the influence of the pipette potential on the cells membrane potential (33). The duration of recordings ranged from 6 to 60 min and was not different between groups (16.1 ± 3.2 vs. 15.1 ± 1.0 min, P > 0.10). Up to four cells per animal were recorded. If no activity was observed for 5 min, 15 mM KCl was added to the bath to check cell viability and recording integrity. If the cell did not respond to KCl, the data set was truncated at the time of last firing. If it fired in response to KCl, the data set was truncated for analysis at the time of adding KCl.
Extracellular recording data collection and analysis
Data were recorded using MultiClamp 700B amplifier (Axon Instruments, Foster City, CA) running Clampex 9.2 software (Axon Instruments) in voltage-clamp mode with a pipette holding potential of 0 mV. Data were filtered at 10 kHz and digitized with a Digidata 1332A (Axon Instruments). Extracellular firing activity (events) was analyzed with the MiniAnalysis program (Synaptosoft Inc., Decatur, GA).
Data are reported as mean ± SEM. Events were counted and binned at 10-sec intervals, and were analyzed for mean firing rate. Firing rate (Hz) was determined in two ways: total events detected during 6 min (duration of the shortest recording) from each cell divided by 360 sec, and total number of events detected from each cell divided by the duration of the recording. No differences arose from these two approaches and the latter is reported.
Statistics
When appropriate, parametric statistics were used with data that satisfied Bartlett tests for equal variances. Otherwise, nonparametric statistics were used. Differences in number of GnRH neurons were analyzed by two-tailed Students t test or Mann-Whitney U test. Data for total neuron numbers and neurons counted in the rostral to caudal serial sections were analyzed using Prism statistics software (GraphPad Software, Inc., San Diego, CA). In electrophysiology experiments, groups were compared with Students t test. Differences were considered significant when P < 0.05.
| Results |
|---|
|
|
|---|
|
|
|
|
Electrophysiology of hpg/GFP neurons
The normal migration and position of GnRH neurons in hpg/GFP mice does not mandate their normal function. To begin to examine the effects of endogenous GnRH on GnRH neuronal activity, we used targeted extracellular recording to study firing activity of GnRH neurons in hpg/GFP mice. Representative examples of firing activity from WT/GFP and hpg/GFP mice are shown in Figure 5A
. There were no significant differences in mean firing rate between groups (Fig. 5B
; P = 0.38). Furthermore, GnRH neurons fired in small bursts of activity as previously described (32, 34, 35), suggesting that the lack of GnRH peptide does not preclude spontaneous generation of bursts of action potentials in GnRH neurons.
|
| Discussion |
|---|
|
|
|---|
The hypothesis that GnRH may developmentally regulate GnRH neurons originated from the distinctive expression of GnRH at times and in a place not associated with GnRH endocrine function—the embryonic nasal compartment (1, 2). To date, however, a function of Gnrh1 expression coincident with the migration of GnRH neurons toward the brain has not yet been demonstrated. Embryonic GnRH expression and peptide processing have been measured (both directly and indirectly) to increase, paralleling maturational events of GnRH neurons, including cytoskeletal changes associated with migration (36, 39, 40, 41). Therefore, a plausible role for GnRH in GnRH neuronal development has been suggested and supporting evidence has been described in different models.
In culture, the addition of exogenous GnRH to FNC-B4, GnRH-secreting cells derived from human olfactory epithelium, induced GnRHR-dependent changes consistent with neuronal differentiation, and included increased GnRH expression combined with down-regulation of nestin expression (37). Furthermore, changes in GnRH-stimulated FNC-B4 cells included axon growth, actin cytoskeleton remodeling and 3- to 4-fold increases in cell motility in Boyden chamber experiments (37). These findings in FNC-B4 cells strongly suggested an autocrine role for GnRH in the differentiation and migration of GnRH neurons. In vivo, a recent study in zebrafish that disrupted GnRH translation early in development by morpholino-modified antisense oligonucleotides altered the pattern of GnRH neuronal migration (38). This observation is a strikingly divergent from our findings in mice, where no deviations in the size or distribution of the adult GnRH neuron population were found despite the biosynthetic deficiency of GnRH or the loss of function of its specific receptor. This may represent a class difference of GnRH neuron development in fishes. Alternatively, the anomalous GnRH neuron development may represent the occasional non-target-related phenotype that can occur in morpholino knockdown experiments that may have simultaneously silenced an essential developmental gene for GnRH neurons (42).
It also may be possible that a part of the Gnrh1 gene or gene product spared in the deletion of exon 2 in hpg mice enables GnRH neuronal migration. This gene product would need to function independently of normal GnRHR signaling because GnRH neuronal migration occurred in Gnrhrmut/mut mice. Furthermore, a second form of GnRH (GnRH2) and a type II GnRH receptor (GnRHR2) exists in most species, and it could be argued that normal development may be mediated through an up-regulation of this second system in the absence of GnRH1 or GnRHR1. The compensatory GnRH2/GnRHR2 hypothesis is unlikely, however, in our model, because this system appears to be absent in mice (43).
We have provided further observations that the heterozygous deletion in the Gnrhr gene in adult male HET mice resulted in the identical reproductive phenotype as their WT counterparts, confirming previous reports (10). Moreover, we can now extend these observations to indicate that a comparable number of hypothalamic GnRH neurons is identified by ICC in the forebrain of HET mice as is found in their WT male littermates. This stands in contrast to an earlier description of an 80% reduction in hypothalamic GnRH content in hpg HET (10), a discrepancy that may reflect differences in methodology. Our observation in 2- to 3-month-old HET male mice suggests little to no effect of haploinsufficiency of the Gnrh1 gene on the GnRH neuronal network or on reproductive capacity.
To circumvent the reliance on potentially unstable Gnrh1 mRNA to identify GnRH neurons in homozygous hpg mice, transgenic GnRH-GFP mice were used, providing a reporter gene to identify the hpg GnRH neurons by crossing the two mouse strains. In these mice, genetically targeted GFP in GnRH neurons identifies 99.5% of GnRH neurons with little ectopic GFP fluorescence (30). GFP-labeled neurons were observed in neuroanatomical regions consistent with appropriate GnRH neuronal distribution in the caudal olfactory bulb, medial septal area, and medial preoptic area, with GFP-positive fibers found in the ME (30). The transgenic GnRH promoter/enhancer activity in hpg/GFP mice effectively directed GFP expression to identify hypothalamic neurons that are morphologically and neuroanatomically similar to GnRH neurons. It should be noted that other cells were observed with low levels of immunodetectable GFP in the brains of all GnRH-GFP mice; these cells appeared consistent with multipolar cells located dorsal and lateral to the normal distribution of GnRH neurons identified in previous reports (44, 45). These cells were detected in all GnRH-GFP genotypes and were distinct from populations of hypothalamic GnRH neurons, thus easily avoided during cell count analysis by their location, size, morphology, and reduced intensity of GFP expression.
We substantiated that GnRH neurons can develop normally independent of GnRH signaling with the corollary experiment that examined the content and distribution of GnRH neurons in the Gnrhrmut/mut mouse generated by ENU mutagenesis (29). The Gnrhrmut/mut mouse has a hypogonadal phenotype similar to the hpg and hpg/GFP mice due to the inability of pituitary gonadotropes to respond to GnRH. These GnRH-insensitive mice provided the next logical avenue to determine whether a GnRHR signaling mechanism was necessary to support the development, differentiation, and maintenance of GnRH neurons. The similar distribution of GnRH neurons in homozygous Gnrhrmut/mut mice and WT control littermates supported the conclusion from the hpg GnRH neuron analysis that developmental regulation and maintenance of adult GnRH neurons is independent of GnRH activation of the GnRHR.
In the present study, the absence of any deficit in the size or the rostral to caudal distribution of the GnRH neuronal population implies that GnRH is not necessary for GnRH neurons to properly differentiate, migrate into the appropriate areas of the brain, extend axons to the ME, or survive into adulthood. The possibility remains that GnRH may act cooperatively to facilitate the activity of other factors. However, unlike the genetic removal or inhibition of other regulators (e.g. FGFR signaling, GABA, and cholecystokinin) which resulted in significant (20–30%) reductions in size of the GnRH neuronal population or disruption of its organization (46, 47, 48), the absence of GnRH signaling did not indicate any partial contribution to GnRH neuronal development. Rather, the completion of GnRH neuron development in the absence of GnRH narrows a potential role of GnRH to post-migratory neurosecretory phases of GnRH neuron differentiation and function.
Beyond effects on migration, autocrine or paracrine GnRH regulation of hypothalamic GnRH neuron function has been proposed to contribute to the regulation of pulsatile GnRH secretion through autocrine or paracrine feedback signaling (49). GnRH is postulated to regulate GnRH neuronal intrinsic pulsatility in vivo, in a GnRH neuronal cell line, in primary GnRH neurons, and in brain slices (13, 28, 50, 51, 52). Models of GnRHR-mediated GnRH autoregulation of pulsatile secretion have been proposed to be both inhibitory or stimulatory (28). Here we show hpg/GFP neurons are capable of firing spontaneous bursts of action potentials, a fundamental component of GnRH neuron function (53). The mean firing rate in the adult hpg/GFP neurons was not significantly different from WT/GFP neurons. hpg/GFP neurons further exhibited individual variability in burst firing similar to wild-type GnRH neurons in previous reports (32, 34, 35). Although GnRH peptide has been reported to alter the activity of GnRH neurons in both stimulatory and inhibitory directions (28, 51, 54), the decapeptide itself is apparently not critical for the genesis of electrical activity by these cells.
Interpretation of the electrophysiological data obtained in ovariectomized female hpg mice, whose male counterparts were used in the ICC studies, indicated that spontaneous neuronal activity occurred in GnRH-deficient neurons. We do not anticipate that this is a gender-specific event, and we expect that male hpg/GFP neurons would be similarly capable of spontaneous firing. Nonetheless, it is possible that sexual dimorphism may exist in WT GnRH neurons and future experiments will explore these questions in hpg GnRH neurons. Moreover, the investigation of electrophysiological responses of hpg/GFP neurons to relevant neuropeptide and hormonal stimuli may reveal as yet undetected effects of GnRH peptide on the electrophysiological properties of GnRH neurons.
In summary, normal GnRH neuronal development occurs in two strains of hypogonadal mice lacking the GnRH decapeptide or expressing inactive GnRHR, respectively. These results indicate that in the absence of GnRH autocrine or paracrine actions, the normal complement of GnRH neurons, become specified in the nasal placode and these neurons migrate normally into the medial basal forebrain to establish appropriate neurosecretory contacts with the ME.
| Acknowledgments |
|---|
| Footnotes |
|---|
Disclosure Statement: The authors have nothing to disclose.
First Published Online May 22, 2008
Abbreviations: ENU, N-ethyl-N-nitrosourea; GFP, green fluorescent protein; GnRHR, GnRH receptor; HET, heterozygous for the Gnrh1 mutation; hpg, hypogonadal; ICC, immunocytochemistry; ME, median eminence; NGS, normal goat serum; NS, normal saline; OVLT, organum vasculosum of the lamina terminalis; TBS, Tris-buffered saline; WT, wild type.
Received March 24, 2008.
Accepted for publication May 14, 2008.
| References |
|---|
|
|
|---|
. Mech Dev 94:79–94[CrossRef][Medline]
-aminobutyric acid and gonadotropin-releasing hormone during neuronal migration through the olfactory system. Endocrinology 137:5415–5420[Abstract]
by the gonadotropin-releasing hormone receptor. Mol Endocrinol 11:738–746
-aminobutyric acid (A) receptor manipulation on migrating gonadotropin-releasing hormone neurons through the entire migratory route in vivo and in vitro. Endocrinology 141:1254–1262This article has been cited by other articles:
![]() |
N. L.G. Miller, R. Wevrick, and P. L. Mellon Necdin, a Prader-Willi syndrome candidate gene, regulates gonadotropin-releasing hormone neurons during development Hum. Mol. Genet., January 15, 2009; 18(2): 248 - 260. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |